Cargando…
Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation
Gut microbiota and short‐chain fatty acids (SCFAs) are associated with the development of various human diseases. In this study, we examined the role of astragaloside IV in modulating mouse gut microbiota structure and the generation of SCFAs, as well as in slow transit constipation (STC). An STC mo...
Autores principales: | He, Qiulan, Han, Changpeng, Huang, Liang, Yang, Haojie, Hu, Jiancong, Chen, Huaxian, Dou, Ruoxu, Ren, Donglin, Lin, Hongcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417726/ https://www.ncbi.nlm.nih.gov/pubmed/32628809 http://dx.doi.org/10.1111/jcmm.15586 |
Ejemplares similares
-
Sodium Butyrate Alleviates Mouse Colitis by Regulating Gut Microbiota Dysbiosis
por: Dou, Xiujing, et al.
Publicado: (2020) -
Zhizhu decoction alleviates slow transit constipation by regulating aryl hydrocarbon receptor through gut microbiota
por: Wen, Yong, et al.
Publicado: (2022) -
Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022) -
Effects of Xiao Chengqi Formula on Slow Transit Constipation by Assessing Gut Microbiota and Metabolomics Analysis in vitro and in vivo
por: Zhou, Qian, et al.
Publicado: (2022) -
Astragaloside IV alleviates placental oxidative stress and inflammation in GDM mice
por: Zhou, Ling, et al.
Publicado: (2020)